PubMed Health⌕ Search

PubMed · 11778755

Perspectives in endoscopic mucosal resection.

Abstract

The birth of endoscopic mucosal resection probably can be traced back to the early days of colonoscopy and polypectomy. With the advent of colonoscopy, endoscopists began encountering pedunculated and sessile mass lesions arising from the mucosal surface. The concept of snare polypectomy developed quickly, and this technique has become the standard of care in the management of colon polyps. Large sessile lesions, however, remain problematic, especially when they arise from the thin wall of the cecum and ascending colon. Serosal burns and frank perforations represent the most significant complication of this technique.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R H Hawes. 2001. Perspectives in endoscopic mucosal resection.. https://pubmed.ncbi.nlm.nih.gov/11778755/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Gastrojejunostomy versus endoscopic stent placement as palliative treatment for a malignant constriction of the duodenum: the SUSTENT-study].

Gastric-outlet obstruction often results from inoperable distal stomach, periampullary (pancreatic or cholangio-), or duodenal carcinoma. Gastrojejunostomy and stent placement are standard palliative treatments. An advantage of gastrojejunostomy is the long-term efficacy; a disadvantage is the prolonged postoperative recovery time. The advantage of stent placement is the rapid ability to consume a soft diet; a disadvantage is that around 20% of the patients require re-intervention because of recurrent symptoms. A randomised multicentre study was started in January 2006 in the Netherlands in which gastrojejunostomy is compared with stent placement in the palliative treatment of malignant gastroduodenal obstruction: 'Surgery versus stent for malignant gastroduodenal obstruction', the SUSTENT-study. The primary-outcome measurement is survival adjusted for the time patients are not able to consume (soft) food. Other outcome measurements are medical effects (complications, re-interventions), quality of life, cost and cost-effectiveness. This study aims to provide individualised recommendations for effective palliative treatment of patients with malignant gastroduodenal obstruction.

Digestive System Neoplasms↗